TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Cronos Australia Ltd. ( (AU:VIT) ) is now available.
Vitura Health Limited has announced its third fully franked dividend of 0.2 cents per share, totaling approximately $1.32 million. The company reported revenues of $124 million and a net profit after tax of $3.1 million for FY2025, marking it as a profitable player in the medicinal cannabis industry. Vitura is also offering a Dividend Reinvestment Plan, allowing shareholders to acquire additional shares at a discount, reflecting its commitment to enhancing shareholder value and continuing its growth strategy.
The most recent analyst rating on (AU:VIT) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Cronos Australia Ltd. stock, see the AU:VIT Stock Forecast page.
More about Cronos Australia Ltd.
Vitura Health Limited is a leading digital health platform in Australia, focusing on traditional and emerging therapies, particularly in the medicinal cannabis space. It is one of the few ASX-listed companies in this sector to generate a profit and declare dividends.
Average Trading Volume: 243,037
Technical Sentiment Signal: Sell
Current Market Cap: A$45.03M
Find detailed analytics on VIT stock on TipRanks’ Stock Analysis page.